Person-centred, evidence-based treatment guide for fentanyl and methamphetamine use disorders in Mexico
This Guide is the result of technical cooperation between the National Commission for Mental Health and Addictions (CONASAMA) and the...
This Guide is the result of technical cooperation between the National Commission for Mental Health and Addictions (CONASAMA) and the...
The National Commission for Mental Health and Addictions of Mexico (CONASAMA), in collaboration with the COPOLAD III Programme and Episteme...
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration...
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of...
The Cooperation Program on Drugs between the EU and Latin America and the Caribbean (COPOLAD III) held on October 27...
The Cooperation Program on Drugs between the EU and Latin America and the Caribbean (COPOLAD III) held on October 27...
In the framework of the international cooperation programs COPOLAD III and EL PACCTO 2.0, financed by the European Union, official...
On 25 September 2025, the Public Prosecutor’s Office of Paraguay, through the Deputy Prosecutor’s Office of the Specialised Unit against...
When our collaboration with the European Union Drugs Agency (EUDA) wrapped up in March this year, it marked the end...
Mexico City hosted, on 11 and 12 September 2025, the Meeting of National Drug Observatories (OND), an event promoted by...
COPOLAD is a consortium formed by:


Collaborating partners:


© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.